
Agilent Technologies is putting about $40 million on the table to roughly double the size of its Chicopee manufacturing site, a move the company says will expand U.S.-based production of laboratory consumables and boost manufacturing capacity in Western Massachusetts. The expansion builds on Agilent’s existing footprint in the city and signals more onshore production for parts that support lab work, with local leaders calling the announcement a win for Chicopee’s industrial tax base and job market.
According to the Boston Business Journal, Agilent rolled out the capital plan on Friday and said it will roughly double the footprint of its Chicopee facility. The outlet reports that the investment is aimed at expanding manufacturing capacity at the site to keep up with rising demand for laboratory supplies.
What Agilent Makes in Chicopee
Agilent’s product materials describe a microplate manufacturing operation in Chicopee that handles molding, assembly and packaging for laboratory microplates and related consumables, capabilities the company says support global lab workflows. Agilent's product pages highlight the microplate work in Chicopee, and local business listings from the Chicopee Chamber of Commerce place Agilent at 300 Griffith Road in the city.
Local Incentives and a Short History
City planning and finance documents show Agilent has worked with Chicopee officials on site conversions and tax-incentive deals tied to manufacturing growth, with the city's financial review referencing an Agilent project on East Main Street expected to create roughly 40 new jobs. State EDIP filings from 2022 outlined earlier plans for about $33.25 million in private investment to modernize a local production site, and public postings from state lawmakers note a small job-creation tax incentive awarded to the company. Together, those filings and local records provide context for the larger $40 million expansion announced this week.
Why It Matters Locally
Economic-development analysts say investments like this help stabilize regional manufacturing payrolls and strengthen supply chains for the life-sciences sector. Industry coverage and regional development reports have pointed to reshoring and capacity-building projects like Agilent’s as part of a broader push to bring critical lab production back to the U.S.
Agilent, city officials and state economic agencies said they will coordinate next steps as the project moves forward. Local leaders framed the investment as a significant boost for Chicopee’s manufacturing future.









-2.webp?w=1000&h=1000&fit=crop&crop:edges)